Alterations in nitric oxide synthase activity and expression in submandibular glands of nod mice

Clinical Immunology

Volumn 101, Issue 1, 2001, Pages 86-93

  Rosignoli, Florencia ^a   Goren, Nora B ^b   Pérez Leirós, Claudia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Autoimmune sialadenitis; Nitric oxide synthase; NOD; NOS isoforms; Salivary glands; VIP

Indexed keywords

AUTOANTIBODY; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW RATE; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SALIVATION; SIALOADENITIS; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; TARGET CELL; TRANSLATION REGULATION;

EID: 0034793757     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5097     Document Type: Article

References (39)

1. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy)
2. Epidemiology of Sjögren's syndrome
3. Approaches to the treatment of Sjögren's syndrome
4. Primary Sjögren's syndrome criteria, clinical features and disease activity
5. Pathogenesis and treatment of Sjögren's syndrome
6. 3 muscarinic receptors in primary Sjögren's syndrome
7. 3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome
8. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies
9. Ultrastructural immunocytochemical submandibulitis in the non-obese diabetic (NOD) mouse
10. Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome
11. Salivary gland cytokine expression in NOD and normal BALB/c mice
12. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation
13. Nitric oxide physiology, pathophysiology and pharmacology
14. Inducible nitric oxide synthase: What difference does it make?
15. Nitric oxide-related vasodilator responses to sympathetic stimulation of the submandibular gland in the cat
16. Role of nitric oxide in salivary secretion
17. Nitric oxide modulates salivary amylase and fluid, but not epidermal growth factor secretion in conscious rats
18. Regulation of biosynthesis of nitric oxide
19. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III)
20. Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies
21. Protein measurement with the Folin phenol reagent
22. Amylase, alpha and beta
23. Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands
24. Nitric oxide and prostaglandin E2 regulate the biological activity of tumor draining lymph nodes in a murine mammary adenocarcinoma
25. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells
26. Role of nitric oxide in Sjögren's syndrome
27. Distribution of nitric oxide synthase containing elements in the feline submandibular gland
28. Functional changes in salivary glands of autoimmune disease-prone NOD mice
29. Genetically programmed development of salivary gland abnormalities in the NOD-scid mouse: A potential trigger for sialoadenitis of NOD mice
30. Developmental coordination of α amylase and PSP gene expression during mouse parotid gland differentiation is controlled posttranscriptionally
31. Activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat parotid
32. VIP as a modulator of lung inflammation and airway constriction
33. Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis
34. Autoimmunity and autoimmune disease
35. Down-regulation of β adrenergic receptors and signal transduction response in salivary glands of NOD mice
36. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice
37. Interaction of human chagasic IgG with the second extracellular loop of the human Heart muscarinic acetylcholine receptor: Functional and pathological implications
38. β-adrenergic cardiac antibody in autoimmune myocarditis
39. The neuroendocrine immune basis of rheumatic diseases